| Clinical Evaluation |
|---|
| Metabolic activity |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| B (generally recommended) |
| Level of Evidence |
| well-established clinical and Nuclear Medicine recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Fassnacht, M., et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment a...
read more
Fassnacht, M., et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; https://doi.org/10.1016/j.annonc.2020.08.460
read less
|
| Guide to Nuclear Medicine |
| Read the corresponding chapter |